ES2059778T5 - Excipiente de liberacion sostenida directamente compresible. - Google Patents
Excipiente de liberacion sostenida directamente compresible.Info
- Publication number
- ES2059778T5 ES2059778T5 ES89309518T ES89309518T ES2059778T5 ES 2059778 T5 ES2059778 T5 ES 2059778T5 ES 89309518 T ES89309518 T ES 89309518T ES 89309518 T ES89309518 T ES 89309518T ES 2059778 T5 ES2059778 T5 ES 2059778T5
- Authority
- ES
- Spain
- Prior art keywords
- directly compressible
- sustained release
- release excipient
- excipient
- heteropolysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
UNA GRANULACION COMPRESIBLE DIRECTAMENTE DE FLUJO LIBRE UTIL COMO EXCIPIENTE DE REPOSICION FARMACEUTICA LENTA ESTA DISPUESTA. EL EXCIPIENTE INCLUYE UNA MATRIZ HIDROFILICA QUE INCLUYE UN MATERIAL HETEROPLISACARIDO Y POLISACARIDO CAPAZ DE UNIR TRANSVERSALMENTE EL HETEROPOLISACARIDO Y UN DILUYENTE INERTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/246,368 US4994276A (en) | 1988-09-19 | 1988-09-19 | Directly compressible sustained release excipient |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2059778T3 ES2059778T3 (es) | 1994-11-16 |
ES2059778T5 true ES2059778T5 (es) | 2003-07-16 |
Family
ID=22930376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89309518T Expired - Lifetime ES2059778T5 (es) | 1988-09-19 | 1989-09-19 | Excipiente de liberacion sostenida directamente compresible. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4994276A (es) |
EP (1) | EP0360562B2 (es) |
JP (1) | JPH0625073B2 (es) |
AT (1) | ATE91887T1 (es) |
AU (1) | AU623182B2 (es) |
CA (1) | CA1339082C (es) |
DE (1) | DE68907835T3 (es) |
ES (1) | ES2059778T5 (es) |
IE (1) | IE65170B1 (es) |
WO (1) | WO1990003165A1 (es) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
US5215752A (en) * | 1988-03-17 | 1993-06-01 | Vectorpharma International S.P.A. | Pharmaceutical tablets and capsule granulates of scleroglucan and active substance |
JP2683391B2 (ja) * | 1988-11-30 | 1997-11-26 | 日清製粉株式会社 | 小麦ふすまからのヘミセルロースを基材とする徐放性組成物 |
US5206168A (en) * | 1991-02-28 | 1993-04-27 | Gregory Boyle | Method for small system wastewater denitrification |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
HU209251B (en) * | 1992-03-13 | 1994-04-28 | Synepos Ag | Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons |
US5472711A (en) * | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
JP2628231B2 (ja) * | 1992-12-30 | 1997-07-09 | エフ エム シー コーポレーション | 放出調整賦形剤として容易に入手できるコンニャクグルコマンナン |
US5330761A (en) * | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
US5993860A (en) * | 1993-06-17 | 1999-11-30 | Venture Lending | NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants |
US5662933A (en) * | 1993-09-09 | 1997-09-02 | Edward Mendell Co., Inc. | Controlled release formulation (albuterol) |
US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5773025A (en) | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US20060263428A1 (en) * | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US5399358A (en) * | 1993-11-12 | 1995-03-21 | Edward Mendell Co., Inc. | Sustained release formulations for 24 hour release of metroprolol |
EP1145712B1 (en) * | 1994-04-25 | 2005-11-02 | Penwest Pharmaceuticals Co. | Sustained release excipient |
US5399362A (en) * | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
JP2656727B2 (ja) * | 1994-05-17 | 1997-09-24 | 財団法人工業技術研究院 | 防湿性漢方顆粒製剤 |
EP0689834A3 (en) * | 1994-07-01 | 1996-06-05 | Willem Jacob Serfontein | Food or feed additive that contains vitamins and minerals with delayed release of active ingredients |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
FR2729857B1 (fr) * | 1995-01-27 | 1997-04-04 | Rhone Poulenc Chimie | Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire |
BE1009380A3 (nl) * | 1995-03-14 | 1997-03-04 | Universiteit Gent Lab Voor Far | Stabiliserend samenstelling voor suspensie. |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5656284A (en) * | 1995-04-24 | 1997-08-12 | Balkin; Michael S. | Oral transmucosal delivery tablet and method of making it |
US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
US5912268A (en) * | 1995-05-22 | 1999-06-15 | Alza Corporation | Dosage form and method for treating incontinence |
US5656294A (en) * | 1995-06-07 | 1997-08-12 | Cibus Pharmaceutical, Inc. | Colonic delivery of drugs |
US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
US6132768A (en) * | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
WO1997026865A1 (en) * | 1996-01-29 | 1997-07-31 | Edward Mendell Co., Inc. | Sustained release excipient |
AU695734B2 (en) * | 1996-07-08 | 1998-08-20 | Penwest Pharmaceuticals Co. | Sustained release matrix for high-dose insoluble drugs |
CA2216215A1 (en) | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
US6210710B1 (en) | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
US6197331B1 (en) | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
IN186245B (es) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
US6416786B1 (en) | 1998-12-11 | 2002-07-09 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
CN1230152C (zh) * | 1999-02-03 | 2005-12-07 | 鲍德杰克特研究有限公司 | 水凝胶颗粒制剂 |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
ES2304980T3 (es) * | 1999-09-30 | 2008-11-01 | Penwest Pharmaceuticals Co. | Sistemas de matriz de liberacion sostenida para farmacos altamente solubles. |
US6500462B1 (en) * | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
US6936275B2 (en) | 1999-12-20 | 2005-08-30 | Scolr, Inc. | Amino acid modulated extended release dosage form |
WO2003024427A1 (en) | 1999-12-20 | 2003-03-27 | Temple University Of The Commonwealth System Of Higher Education | Tableted oral extended release dosage form |
US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US6372252B1 (en) | 2000-04-28 | 2002-04-16 | Adams Laboratories, Inc. | Guaifenesin sustained release formulation and tablets |
US7056531B1 (en) | 2000-05-04 | 2006-06-06 | Nature's Way Products, Inc. | Sustained release compositions for orally administered substances and methods |
US7130822B1 (en) * | 2000-07-31 | 2006-10-31 | Cognos Incorporated | Budget planning |
AU9497901A (en) * | 2000-10-03 | 2002-04-15 | Penwest Pharmaceuticals Compan | Delivery system for multi-pharmaceutical active materials at various release rates |
EP1339395A2 (en) | 2000-11-28 | 2003-09-03 | Fmc Corporation | Edible pga (propylene glycol alginate) coating composition |
US6932861B2 (en) | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
AU2141202A (en) | 2000-12-05 | 2002-06-18 | Alexander Macgregor | Hydrostatic delivery system for controlled delivery of agent |
HUP0501071A3 (en) * | 2001-03-13 | 2007-06-28 | Penwest Pharmaceutical Co | Chronotherapeutic dosage forms |
BR0210855A (pt) * | 2001-07-06 | 2006-10-24 | Penwest Pharmaceuticals Compan | Método de fabricação de formulações de liberação prolongada |
ES2284888T3 (es) * | 2001-07-06 | 2007-11-16 | Endo Pharmaceuticals Inc. | Administracion oral de 6-hidroxi-oximorfona utilizada como analgesico. |
US8329216B2 (en) * | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
US20050191361A1 (en) * | 2001-08-03 | 2005-09-01 | Powederject Research Ltd. | Hydrogel particle formation |
EP1429730A4 (en) * | 2001-09-26 | 2010-06-16 | Penwest Pharmaceuticals Compan | OPIOID FORMULATIONS WITH REDUCED ABUSE POTENTIAL |
WO2003086353A1 (en) * | 2002-04-05 | 2003-10-23 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
EP1549296A4 (en) * | 2002-08-02 | 2006-08-09 | Penwest Pharmaceuticals Co | METFORMIN FORMULATIONS WITH DELAYED RELEASE |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20040091544A1 (en) * | 2002-11-08 | 2004-05-13 | Ruff Michael D. | Coated dibasic calcium phosphate |
ATE390122T1 (de) * | 2003-09-01 | 2008-04-15 | Jpm The Jordanian Pharmaceutic | Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat |
JP2007505921A (ja) * | 2003-09-19 | 2007-03-15 | ペンウェスト ファーマシューティカルズ カンパニー | 遅延放出剤形 |
US20050118267A1 (en) * | 2003-09-19 | 2005-06-02 | Penwest Pharmaceuticals Co. | Chronotherapeutic dosage forms |
US20060105044A1 (en) | 2004-05-20 | 2006-05-18 | Singh Bramah N | Sustained release formulations of sotalol |
CA2585926C (en) | 2004-11-02 | 2015-04-14 | Gangagen Life Sciences Inc. | Stabilized bacteriophage formulations |
WO2006094083A1 (en) * | 2005-02-28 | 2006-09-08 | Penwest Pharmaceuticals Co. | Controlled release venlafaxine formulations |
EP1743638A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
WO2007009683A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr.Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
US20070212414A1 (en) * | 2006-03-08 | 2007-09-13 | Penwest Pharmaceuticals Co. | Ethanol-resistant sustained release formulations |
WO2007137216A2 (en) * | 2006-05-22 | 2007-11-29 | Janssen Pharmaceutica, N.V. | Gastroretentive sustained release formulations |
CA2664641A1 (en) * | 2006-09-26 | 2008-04-10 | Astellas Pharma, Inc. | Controlled release dosage form of tacrolimus |
JP5422388B2 (ja) * | 2006-10-10 | 2014-02-19 | ペンウェスト ファーマシューティカルズ カンパニー | ロバスト性持続放出製剤 |
US20080085304A1 (en) * | 2006-10-10 | 2008-04-10 | Penwest Pharmaceuticals Co. | Robust sustained release formulations |
US20080085303A1 (en) * | 2006-10-10 | 2008-04-10 | Penwest Pharmaceuticals Co. | Robust sustained release formulations of oxymorphone and methods of use thereof |
US20080085305A1 (en) * | 2006-10-10 | 2008-04-10 | Penwest Pharmaceuticals Co. | Robust sustained release formulations of oxymorphone |
MX2009005478A (es) | 2006-11-27 | 2009-08-12 | Lundbeck & Co As H | Derivados de heteroarilamida. |
CA2674039A1 (en) * | 2006-12-28 | 2008-07-17 | Astellas Pharma Inc. | Sustained release formulation for tacrolimus |
US20090042795A1 (en) * | 2007-06-05 | 2009-02-12 | Pasan Fernando | Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation |
US20080318994A1 (en) | 2007-06-21 | 2008-12-25 | Endo Pharmaceuticals, Inc. | Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment |
US20090124650A1 (en) * | 2007-06-21 | 2009-05-14 | Endo Pharmaceuticals, Inc. | Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol |
JP5463537B2 (ja) * | 2008-02-22 | 2014-04-09 | HOYA Technosurgical株式会社 | 分離方法 |
US7928189B2 (en) * | 2008-05-05 | 2011-04-19 | Ottawa Health Research Institute | PCSK9 polypeptide fragment |
LT2400950T (lt) | 2009-02-26 | 2019-08-26 | Glaxo Group Limited | Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
EP2554168B1 (en) | 2010-03-29 | 2018-01-24 | Astellas Pharma Inc. | Controlled release pharmaceutical composition |
WO2013142482A1 (en) | 2012-03-20 | 2013-09-26 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
FR3020571B1 (fr) * | 2014-05-05 | 2017-08-25 | Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic | Co-granules de gomme de xanthane et de gomme d'acacia |
EP3288570A4 (en) | 2015-04-29 | 2018-11-21 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
US10166185B2 (en) | 2015-06-09 | 2019-01-01 | J. Rettenmaier & Söhne Gmbh + Co Kg | Excipient and oral solid dosage forms for oily drugs |
WO2017062997A1 (en) | 2015-10-09 | 2017-04-13 | Reckitt Benckiser Llc | Pharmaceutical formulation |
GB201607518D0 (en) * | 2016-04-29 | 2016-06-15 | Andalay Technologies Ltd | Mouthwash composition |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2993836A (en) * | 1958-02-20 | 1961-07-25 | Dow Chemical Co | Sustained release tablets |
US3079303A (en) * | 1958-12-11 | 1963-02-26 | Smith Kline French Lab | Basic tablet granulation and process of using same |
BE604564A (es) * | 1960-06-06 | |||
US3133863A (en) * | 1961-03-10 | 1964-05-19 | Strong Cobb Arner Inc | Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums |
US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
US3388041A (en) * | 1964-01-27 | 1968-06-11 | Richardson Merrell Inc | High dosage sustained release tablet |
GB1097207A (en) * | 1964-08-24 | 1967-12-29 | Collett & Co As | Process for the preparation of sustained action tablets |
US3456049A (en) * | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
US3726690A (en) * | 1965-10-22 | 1973-04-10 | Kelco Co | Acidified food products containing xanthomonas colloid |
US3864469A (en) * | 1967-12-16 | 1975-02-04 | Hoechst Ag | Xanthines in pharmaceutical preparations and for stabilization of vitamins |
US3639169A (en) * | 1969-04-29 | 1972-02-01 | Sucrest Corp | Direct compression vehicles and method therefor |
US3627583A (en) * | 1969-04-29 | 1971-12-14 | Sucrest Corp | Direct compression vehicles |
US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
GB1359643A (en) * | 1970-09-28 | 1974-07-10 | Controlled Medications | Controlled release medicament |
US4072535A (en) * | 1970-12-28 | 1978-02-07 | A. E. Staley Manufacturing Company | Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules |
US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
US3836618A (en) * | 1971-12-23 | 1974-09-17 | American Home Prod | Process for the uniform distribution of a drug on a granulated base |
FR2183546B1 (es) * | 1972-05-10 | 1975-06-20 | Servier Lab | |
US3963832A (en) * | 1973-01-24 | 1976-06-15 | Teijin Limited | Liquid or pasty dentifrice and process for its preparation |
US4013820A (en) * | 1974-11-07 | 1977-03-22 | Abbott Laboratories | Universally useable tableting ingredients |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
US4361545A (en) * | 1979-05-21 | 1982-11-30 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion |
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
US4308251A (en) * | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
US4439453A (en) * | 1980-12-22 | 1984-03-27 | Monsanto Company | Directly compressible acetaminophen granulation |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
US4525345A (en) * | 1981-12-24 | 1985-06-25 | Verex Laboratories, Inc. | Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4556678A (en) * | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
US4698264A (en) * | 1982-08-02 | 1987-10-06 | Durkee Industrial Foods, Corp. | Particulate composition and process for making same |
US4698101A (en) * | 1982-08-30 | 1987-10-06 | Suomen Sokeri Oy (Finnish Sugar Company Ltd.) | Binder-diluent composition and method |
DE3435325A1 (de) * | 1983-04-09 | 1986-04-17 | Nikken Chemicals Co., Ltd., Tokio/Tokyo | Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung |
US4717713A (en) * | 1983-10-31 | 1988-01-05 | Research Corporation | Controlled release liquid pharmaceutical |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
JPS6124516A (ja) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
DE3440288C2 (de) * | 1984-11-05 | 1987-03-12 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung |
EP0227814A1 (en) * | 1985-07-02 | 1987-07-08 | The Upjohn Company | Therapeutic formulations with bimodal release characteristics |
GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
GB8522453D0 (en) * | 1985-09-11 | 1985-10-16 | Lilly Industries Ltd | Chewable capsules |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
IT1191674B (it) * | 1986-03-07 | 1988-03-23 | Eurand Spa | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
GB8608818D0 (en) * | 1986-04-11 | 1986-05-14 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
JPH0826346B2 (ja) * | 1986-07-10 | 1996-03-13 | 株式会社林原生物化学研究所 | 固状油溶性物質の製法 |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
-
1988
- 1988-09-19 US US07/246,368 patent/US4994276A/en not_active Expired - Lifetime
-
1989
- 1989-09-14 JP JP1510135A patent/JPH0625073B2/ja not_active Expired - Lifetime
- 1989-09-14 WO PCT/US1989/003968 patent/WO1990003165A1/en unknown
- 1989-09-14 AU AU43057/89A patent/AU623182B2/en not_active Expired
- 1989-09-18 CA CA000611700A patent/CA1339082C/en not_active Expired - Lifetime
- 1989-09-18 IE IE296889A patent/IE65170B1/en not_active IP Right Cessation
- 1989-09-19 ES ES89309518T patent/ES2059778T5/es not_active Expired - Lifetime
- 1989-09-19 DE DE68907835T patent/DE68907835T3/de not_active Expired - Lifetime
- 1989-09-19 AT AT89309518T patent/ATE91887T1/de not_active IP Right Cessation
- 1989-09-19 EP EP89309518A patent/EP0360562B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0625073B2 (ja) | 1994-04-06 |
ATE91887T1 (de) | 1993-08-15 |
CA1339082C (en) | 1997-07-29 |
WO1990003165A1 (en) | 1990-04-05 |
EP0360562A3 (en) | 1990-11-22 |
DE68907835D1 (de) | 1993-09-02 |
EP0360562B2 (en) | 2002-12-11 |
ES2059778T3 (es) | 1994-11-16 |
US4994276A (en) | 1991-02-19 |
AU4305789A (en) | 1990-04-18 |
JPH04501713A (ja) | 1992-03-26 |
IE892968L (en) | 1990-03-19 |
DE68907835T3 (de) | 2003-09-18 |
DE68907835T2 (de) | 1993-11-11 |
IE65170B1 (en) | 1995-10-04 |
EP0360562B1 (en) | 1993-07-28 |
EP0360562A2 (en) | 1990-03-28 |
AU623182B2 (en) | 1992-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059778T3 (es) | Excipiente de liberacion sostenida directamente compresible. | |
FI954989A (fi) | Lääkelaastari | |
ES2099273T3 (es) | Comprimidos de verapamil de liberacion controlada. | |
HUT59005A (en) | Process for producing transdermal pharmaceutical preparations containing 2-amino-6-(propyl-amino)-4,5,6,7-tetrahydro-benzothiazole | |
NO901419L (no) | Apparat for fluidisering, avgassing og pumping av en suspensjon av fiberholdig cellulosemateriale. | |
DE69022257D1 (de) | Optischer Halbleiterschalter und Schaltermatrix. | |
ES2060016T3 (es) | Composicion de champu. | |
ES2073701T3 (es) | Comprimido de liberacion prolongada a base de 5-mononitrato de isosorbido y su procedimiento de preparacion. | |
DE59009872D1 (de) | (4-Arylbutyl)cyclohexan-Derivate. | |
AU648369B2 (en) | Salinomycin biomass granules which are free-flowing and dust-free and have unrestricted bioavailability of active substance, and a process for the production thereof | |
NO177348C (no) | Fremgangsmåte til fremstilling av et cefalosporin-antibiotikum, samt 3-(fluorsulfonyl)oksy-substituerte cefemer og karbacefemer | |
NO921509D0 (no) | Suspensjonspolymer, samt fremgangsmaate for fremstilling av en slik polymer | |
NO900653D0 (no) | Nytt industrielt antimikrobemiddel: anvendelser av 2-(2-bromo-2-nitroethenyl)-furan og en fremgangsmaate for fremstilling av 2-(2-bromo-2-nitroethenyl)-furan. | |
ES2097618T3 (es) | Formulacion de aerosol a base de fusafungina. | |
RU2005177C1 (ru) | Горный комбайн | |
EP0393597A3 (en) | Contact device | |
DE68926480D1 (de) | Hochdruck-Photolack Siliconisierungsverfahren und Vorrichtung | |
NO900588D0 (no) | Verktoey for utskifting av roermodul. | |
CA2027773A1 (en) | Treatment of shock by cyclodextrins and their derivatives | |
DK137788D0 (da) | Som granulat foreliggende dertergentenzymprodukt, fremgangsmaade til fremstilling deraf, anvendelse deraf og detergent indeholdende et saadant produkt | |
IT214723Z2 (it) | Pressa radiale per la vulcanizzazione di pneumatici. | |
EP0403325A3 (fr) | Acide diallyloxyacétique et ses sels d'addition basiques, leur procédé de préparation et leur application comme agent réticulant | |
ES1010226Y (es) | Diafragma de obturacion neumatica. | |
DZ1217A1 (fr) | Procédé de préparation de n-n-(dibenzohexatrienylène) urées. | |
IT8819639A0 (it) | Derivati ammidici del bendazac. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 360562 Country of ref document: ES |